Group One Trading’s Aratana Therapeutics, Inc. PETX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,300
Closed -$7K 5879
2019
Q2
$7K Sell
1,300
-8,700
-87% -$39.1K ﹤0.01% 4541
2019
Q1
$36K Buy
10,000
+8,000
+400% +$34.7K ﹤0.01% 3743
2018
Q4
$12K Sell
2,000
-8,000
-80% -$48.8K ﹤0.01% 4216
2018
Q3
$58K Sell
10,000
-5,600
-36% -$28K ﹤0.01% 3889
2018
Q2
$66K Buy
+15,600
New +$78.7K ﹤0.01% 3807
2017
Q1
Sell
-500
Closed -$4K 5231
2016
Q4
$4K Sell
500
-200
-29% -$1.62K ﹤0.01% 4172
2016
Q3
$7K Sell
700
-16,200
-96% -$135K ﹤0.01% 4158
2016
Q2
$107K Buy
+16,900
New +$109K ﹤0.01% 2822
2016
Q1
Sell
-2,900
Closed -$16K 5211
2015
Q4
$16K Sell
2,900
-500
-15% -$3.3K ﹤0.01% 4024
2015
Q3
$29K Buy
+3,400
New +$57.5K ﹤0.01% 3866
2015
Q2
Sell
-200
Closed -$3K 5361
2015
Q1
$3K Buy
+200
New +$3.56K ﹤0.01% 4517

Other funds holding PETX

Group One Trading's PETX Position: Q3 2019 in Review

Group One Trading sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 1,900 shares — an estimated $10K sold.

Group One Trading first reported a position in PETX in Q2 2014 and held it in 16 quarters. The position peaked at $395K in Q1 2017. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Group One Trading reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Group One Trading sold 1,900 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $10K.
  • Group One Trading first reported a position in Aratana Therapeutics, Inc. in Q2 2014 and held it in 16 quarters.
  • Group One Trading's Aratana Therapeutics, Inc. position peaked at $395K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.